1. Beggs, M. HTS: where next? Drug Disc World. 2001, 2, 25-30.

2. Kell, D. Screensavers: trends in high-throughput analysis. Trends Biotechnol. 1999, 17, 89-91.

3. Lavery, P.; Brown, M.J.; Pope, A.J. Simple absorbance-based assays for ultra-high throughput screening. J Biomol Screen. 2001, 6, 3-9.

4. Burns, D.J; Kofron, J.L.; Warrior, U.; Beutel, B.A. Well-less, gel permeation formats for ultra-HTS. Drug Disc Today. 2001, 6, S40-S47.

5. Hodgson, J. Receptor screening and the search for new pharmaceuticals. Biotechnology. 1992, 10, 973-980.

6. Knight, PJ.; Pfeifer, T.A.; Grigliatti, T.A. A functional assay for G-protein-coupled receptors using stably transformed insect tissue culture cell lines. Anal Biochem. 2003, 320, 88-103.

7. Jamieson, A.C.; Miller, J.C.; Pabo, C.O. Drug discovery with engineered zinc finger proteins. Nat Rev. Drug Disc. 2003, 2,361-368.

8. Qureshi, S.A.; Sanders, P; Zeh, K.; Whitney, M.; Pollok, B.; Desai, R.; Whitney. P; Robers, M.; Hayes, S.A. A one-arm homologous recombination approach for developing nuclear receptor assays in somatic cells. Assay Drug Dev Technol. 2003, 1, 767-776.

9. Zeh, K.; Sanders, P.; Londo, P.; Crute, J.J.; Pollok, B.A.; Whitney, M.A. Gain-of-function somatic cell lines for drug discovery applications generated by homologous recombination. Assay Drug Dev Technol. 2003, 1, 755-765.

10. Vanhauwe, J.F.; Ercken, M.; van de Wiel, D.; Jurzak, M.; Leysen, J.E. Effects of recent and reference antipsychotic agents at human dopamine D2 and D3 receptor signaling in Chinese hamster ovary cells. Psychopharmacology. 2000, 150, 383-390.

11. Zhang, J-H.; Chung, T.D.Y.; Oldenburg, K.R.; A simple statistical parameter for use in evaluation and validation of high throughput screening. J Biomol Screen. 1999, 4, 67-73.

12. Cheng, X.; Hochlowski, J.; Tang, H.; Hepp, D.; Beckner, C.; Kantor, S.; Schmitt, R. Studies on repository compound stability in DMSO under various conditions. J Biomol Screen. 2003, 8, 292-304.

13. Kozikowski, B.A.; Burt, T.M.; Tirey, D.A.; Williams, L.E.; Kuzmak, B.R.; Stanton, D.T.; Morand, K.L.; Nelson, S.L. The effect of room temperature storage on the stability of compounds in DMSO. J Biomol Screen. 2003, 8, 205-209.

14. Kozikowski, B.A.; Burt, T.M.; Tirey, D.A; Williams, L.E.; Kuzmak, B.R.; Stanton, D.T.; Morand, K.L.; Nelson, S.L. The effect of freeze/thaw cycles on the stability of compounds in DMSO. J Biomol Screen. 2003, 8, 210-215.

15. Vanhauwe, J.F.M.; Fraeyman, N.; Francken, B.J.B; Luyten, W.H.M.L.; Leysen, J.E. Comparison of the ligand binding and signaling properties of human dopamine D2 and D3 receptors in Chinese hamster ovary cells. J Pharm Exp Ther. 1999, 290, 908-916.

16. Vanhauwe, J.F.M.; Josson, J.F.M; Luyten, W.H.M.L; Driessen, A.J.M.; Leysen, J.E. G-protein sensitivity of ligand binding to human dopamine D2 and D3 receptors expressed in E. coli: clues for a constrained D3 receptor structure. J Pharm Exp Ther. 2000, 295, 274-283.

17. Cook, N.D. Scintillation proximity assay: a versatile high-throughput screening technology. Drug Disc Today. 1996, 1, 287-294.

18. Lowitz, K.; Prescott, G.; Guyer, D.; Dunst, R. Comparison of human ghrelin receptor binding assays using SPA and the LEADseeker multimodality imaging system. Society for Biomolecular Screening 9th Annual Conference, Portland, OR, September 21-25, 2003. Danbury, CT, p. 189.

19. Miraglia, S.; Swartzman, E.E.; Mellentin-Michelotti, J.; Evangelista, L.; Smith, C.; Gunawan, I. I.; Lohman, K.; Goldberg, E.M.; Manian, B.; Yuan, P.M. Homogeneous cell- and bead-based assays for high throughput screening using fluorometric microvolume assay technology. J Biomol Screen. 1999, 4, 193-204.

20. Banks, P; Harvey, M. Considerations for using fluorescence polarization in screening of G protein-coupled receptors. J Biomol Screen. 2002, 7, 111-117.

21. Banks, P.; Gosselin, M.; Prystay, L. Impact of a red-shifted dye label for high throughput fluorescence polarization assays of G protein-coupled receptors. J Biomol Screen. 2000, 5, 329-334.

22. Harris, A.; Cox, S.; Burns, D.; Norey, C. Miniaturization of fluorescence polarization receptor-binding assays using CyDye-labeled ligands. J Biomol Screen. 2003, 8, 410-420.

23. Sprang, S.R. G protein mechanisms: insights from structural analysis. Annu Rev Biochem. 1997, 66, 639-678.

24. Hamm, H.E. The many faces of G protein signaling. J Biol Chem. 1998, 273, 669-672.

25. Strathmann, M.P; Simon, M.I. Ga12 and Ga13 subunits define a fourth class of G protein subunits. Proc Natl Acad Sci USA. 1991, 88, 5582-5586.

26. Simon, M.I.; Strathmann, M.P; Gautam.N. Diversity of G proteins in signal transduction. Science. 1991, 252, 802-808.

27. Suzuki, N.; Nakamura, S.; Mano, H.; Kozasa, T. Ga12 activates Rho GTPase through tyrosine-phosphorylated leukemia-associated RhoGEF, Proc Natl Acad Sci USA. 2003, 100, 733-738.

28. Cabrera-Vera, T.M.; Vanhauwe, J.; Thomas, T.O.; Medkova, M.; Preininger, A.; Maz-zoni, M.R; Hamm, H.E. Insights into G protein structure, function, and regulation. Endocr Rev. 2003, 24, 765-781.

29. Harrison, C.; Traynor, J.R. The [35S]GTPgS binding assay: approaches and applications in pharmacology, Life Sci. 2003, 74, 489-508.

30. Lazareno, S.; Farries, T.; Birdsall, N.J. Pharmacological characterization of guanine nucleotide exchange reactions in membranes from CHO cells stably transfected with human muscarinic receptors M1-M4. Life Sci. 1993, 52, 449-456.

31. Offermanns, S.; Wieland, T.; Homann, D.; Sandmann, J.; Bombien, E.; Spicher, K.; Schultz, G.; Jakobs, K.H. Transfected muscarinic acetylcholine receptors selectively couple to Gj-type G proteins and Gq/11. Mol Pharmacol. 1994, 45, 890-898.

32. Birnbaumer, L.; Abramowitz, J.; Brown, A.M. Receptor-effector coupling by G proteins. Biochim Biophys Acta. 1990, 1031, 163-224.

33. Tian, W.N.; Duzic, E.; Lanier, S.M.; Deth, R.C. Determinants of b2-adrenergic receptor activation of G proteins: evidence for a precoupled receptor/G protein state. Mol Pharmacol. 1994, 45, 524-531.

34. Selley, D.E.; Cao, C.C.; Liu, Q.; Childers, S.R. Effects of sodium on agonist efficacy for G-protein activation in (m-opioid receptor-transfected CHO cells and rat thalamus. Br J Pharmacol. 2000, 130, 9879-9896.

35. Milligan, G. Principles: extending the utility of [35S]GTPgS binding assays. Trends Pharmacol Sci. 2003, 24, 87-90.

36. Ferrer, M.; Kolodin, G.D.; Zuck, P.; Peltier, R.; Berry, K.; Mandala, S.M.; Rosen, H.; Ota, H.; Ozaki, S.; Inglese, J.; Strulovici, B. A fully automated [35S]GTPgS scintillation proximity assay for the high throughput screening of Gi-linked G proteincoupled receptors. Assay Drug Dev Technol. 2003, 1, 261-273.

37. Frang. H.; Mukkala, V.M.; Syysto, R.; Ollikka, P.; Hurskainen, P.; Scheinin, M.; Hemmila, I. Nonradioactive GTP binding assay to monitor activation of G proteincoupled receptors, Assay Drug Dev Technol. 2003, 1, 275-280.

38. Hanoune, J.; Defer, N. Regulation and role of adenylyl cyclase isoforms. Annu Rev Pharmacol Toxicol. 2001, 41, 145-174.

39., Williams, C. cAMP detection methods in HTS: selecting the best from the rest. Nat Rev Drug Disc. 2004, 3, 125-135.

40. NEN Life Science Products. A novel adenylyl cyclase activation assay on FlashPlate (application note). Boston, MA, 1998.

41. Kariv, I.; I.; Stevens, M.E.; Behrens, D.L.; Oldenburg, K.R. High throughput quantitation of cAMP production mediated by activation of seven-transmembrane domain receptors. J Biomol Screen. 1999, 4, 27-32.

42. Amersham Biosciences. High throughput screening for cAMP formation by scintillation proximity radioimmunoassay. Proximity News, 23, 1996.

43. Amersham Biosciences. Miniaturization of the cAMP SPA direct screening assay to 384-well format. Proximity News, 57, 1998.

44. Prystay, L.; Gagne, A.; Kasila, P.; Yeh, L.A.; Banks, P. Homogeneous cell-based fluorescence polarization assay for the direct detection of cAMP J Biomol Screen. 2001, 6, 75-82.

Allen, M.; Hall, D.; Collins, B.; Moore, K. A homogeneous high throughput nonradioactive method for measurement of functional activity of Gs-coupled receptors in membranes. J Biomol Screen. 2002, 7, 35-44.

Horton, J., Gardner, N.; Tinkler, S.; Cox, C.; Norey, M.; Briggs, M.; Baxendale, P. A simple, non-radioactive, functional assay for compound screening at G-protein coupled receptors: drug screening and cellular assays, Amersham Biosciences, Life Science News Online, 2003.

Degorce, F.; Cougouluegne, F.; Jacquemart, L.; Preaudat, M.; Achard, S.; Enomoto, K.; Ohta, H.; Nishigaki, A.; Dohi, K.; Takemoto, H.; Seguin, P.; Mathis G. Assessment of tumor necrosis factor alpha (TNF) in cell culture with a new HTRF assay. Society for Biomolecular Screening 6th Annual Conference, Vancouver, Canada, September 2000. Danbury, CT, p. 186.

Gabriel, D.; Vernier, M.; Pfeifer, M.J.; Dasen, B.; Tenaillon, L.; Bouhelal, R. High throughput screening technologies for direct cyclic AMP measurement. Assay Drug Dev Technol. 2003, 1, 291-303.

Bosse, R.; Bouchard, N.; Chelsky, D.; Howard, B. Alphascreen™: true format flexibility 96 to 384 to 1536 cAMP assays. Society for Biomolecular Screening 6th Annual Conference, Vancouver, Canada, September 2000. Danbury, CT, p. 176. Golla, R.; Seethala, R. A homogeneous enzyme fragment complementation cyclic AMP screen for GPCR agonists. J Biomol Screen. 2002, 7, 515-525. Weber, M.; Ferrer, M.; Zheng, W.; Inglese, J.; Strulovici, B.; Kunapuli, P A. 1536-well cAMP assay for Gs- and Gi-coupled receptors using enzyme fragmentation complementation. Assay Drug Dev Technol. 2004, 2, 39-49. De Cesare, D.; Fimia, G.M.; Sassone-Corsi, P. Signaling routes to CREM and CREB: plasticity in transcriptional activation. Trends Biochem Sci. 1999, 24, 281-285. Hill, S.J.; Baker, J.G.; Rees, S. Reporter gene systems for the study of G-protein-coupled receptors. Curr Opin Pharmacol. 2001, 1, 526-532.

Naylor, L.H. Reporter gene technology: the future looks bright. Biochem Pharmacol 1999, 5, 749-757.

Zlokarnik, G.; Negulescu, P. A.; Knapp, T.E.; Mere, L.; Burres, N.; Feng, L.; Whitney, M.; Roemer,K.; Tsien, R.Y. Quantitation of transcription and clonal selection of single living cells with b-lactamase as reporter. Science. 1998, 279, 84-88. Kunapuli, P.; Ransom, R.; Murphy, K.L.; Pettibone, D.; Kerby, J.; Grimwood, S.; Zuck, P; Hodder, P.; Lacson, R.; Hoffman, I.; Inglese, J.; Strulovici, B. Development of an intact cell reporter gene b-lactamase assay for G protein-coupled receptors for high-throughput screening. Anal Biochem. 2003, 314, 16-29. Liu, B.; Wu, D. Analysis of the coupling of G12/13 to G protein-coupled receptors using a luciferase reporter assay. Methods Mol Biol. 2004, 237, 145-149. Langmead, C.; Patel, N.; Ratti, E.; Heath, J.; Wood, M. Act one: a novel real-time cAMP assay using the FLIPR. Eighth International Drug Discovery Conference, June 2004, Molecular Devices Corporation, Berkeley Hills, CA.

Schroeder, K.S.; Neagle, B.D. FLIPR: a new instrument for accurate, high throughput optical screening. J Biomol Screen. 1996, 1, 75-80.

Miller,T.R.; Witte, D.G.; Ireland, L.M.; Kang, C.H.; Roch, J.M.; Masters, J.N.; Esben-shade, T.A.; Hancock, A.A. Analysis of apparent non-competitive responses to competitive H1 histamine receptor antagonists in fluorescent imaging plate reader-based calcium assays. J Biomol Screen. 1999, 4, 249-258.

Stables, J. Evaluation of FLIPR Tetra instrument for 384- and 1536-well calcium mobilization assays. Eighth International Drug Discovery Conference, June 2004, Molecular Devices Corporation, Berkeley Hills, CA.

62. Kaler, G.; Otto, M.; Okun, A.; Okun, I. Serotonin antagonist profiling on 5HT2A and 5HT2C receptors by nonequilibrium intracellular calcium response using an automated flow-through fluorescence analysis system, HT-PS 100. J Biomol Screen. 2002, 7, 291-301.

63. Coward, P.; Chan, S.D.; Wada, H.G.; Humphries, G.M.; Conklin, B.R. Chimeric G proteins allow a high-throughput signaling assay of Grcoupled receptors. Anal Bio-chem. 1999, 270, 242-248.

64. Milligan, G.; Marshall, F.; Rees, S. G16 as a universal G protein adapter: implications for agonist screening strategies. Trends Pharmacol Sci. 1996, 17, 235-237.

65. Mody, S.M.; Ho, M.K.; Joshi, S.A.; Wong, Y.H. Incorporation of Ga(z)-specific sequence at the carboxyl terminus increases the promiscuity of Ga(16) toward G(i)-coupled receptors. Mol Pharmacol. 2000, 57, 13-23.

66. Elshourbagy, N.A.; Ames, R.S.; Fitzgerald, L.R.; Foley, J.J.; Chambers, J.K.; Szek-eres, P.G.; Evans, N.A.; Schmidt, D.B.; Buckley, P.T.; Dytko, G.M.; Murdock, P.R.; Milligan, G.; Groarke, D.A.; Tan, K.B.; Shabon, U.; Nuthulaganti, P; Wang, D.Y.; Wilson, S.; Bergsma, D.J.; Sarau, H.M. Receptor for the pain modulatory neuropep-tides FF and AF is an orphan G protein-coupled receptor. J Biol Chem. 2000, 275, 25965-25971.

67. Chambers, J.K.; Macdonald, L.E.; Sarau, H.M.; Ames, R.S.; Freeman, K.; Foley, J.J.; Zhu, Y.; McLaughlin, M.M.; Murdock, P; McMillan, L.; Trill, J.; Swift, A.; Aiyar, N.; Taylor, P.; Vawter, L.; Naheed, S.; Szekeres, P.; Hervieu, G.; Scott, C.; Watson, J.M.; Murphy, A.J.; Duzic, E.; Klein, C.; Bergsma, D.J.; Wilson, S.; Livi, G.P. A G protein-coupled receptor for UDP glucose. J Biol Chem. 2000, 275, 10767-10771.

68. Lai, F.P.; Mody, S.M.; Yung, L.Y.; Kam, J.Y.; Pang, C.S.; Pang, S.F.; Wong, Y.H Molecular determinants for the differential coupling of G16 to the melatonin MT1, MT2 and Xenopus Mel1c receptors. J Neurochem. 2002, 80, 736-745.

69. Marchese, A.; George, S.R.; Kolakowski, L.F. Jr.; Lynch, K.R.; O'Dowd, B.F. Novel GPCRs and their endogenous ligands: expanding the boundaries of physiology and pharmacology. Trends Pharmacol Sci. 1999. 20, 370-375.

70. Lee, C.H.; Shin, I.C.; Kang, J.S.; Koh, H.C.; Ha, J.H.; Min. C.K. Differential coupling of Gq family of G-proteins to muscarinic M1 receptor and neurokinin-2 receptor. Arch Pharm Res. 1998, 21, 423-428.

71. Liu, A.M.; Ho, M.K.; Wong, C.S.; Chan, J.H.; Pau, A.H.; Wong, Y.H. Ga(16/z) chimeras efficiently link a wide range of G protein-coupled receptors to calcium mobilization. J Biomol Screen. 2003. 8, 39-49.

72. Wong, S.; Shirikhande, A. Functional assay for agonist activation of receptors, US2003.0104489A1, 2002.

73. Gopalakrishnan, S.M.; Moreland, R.B.; Kofron, J.L.; Helfrich, R.J.; Gubbins, E.; McGowen, J.; Masters, J.N.; Donnelly-Roberts, D.; Brioni, J.D.; Burns, D.J.; Warrior, U. A cell-based microarrayed compound screening format for identifying agonists of G-protein-coupled receptors. Anal Biochem. 2003, 321, 192-201.

74. Ungrin, M.D.; Singh, L.M.; Stocco, R.; Sas, D.E.; Abramovitz, M. An automated aequorin luminescence-based functional calcium assay for G-protein-coupled receptors. Anal Biochem. 1999. 272, 34-42.

75. Chen, W. J.; Jayawickreme, C.; Watson, C.; Wolfe, L.; Holmes, W.; Ferris, R.; Armour, S.; Dallas, W.; Chen, G.; Boone, L.; Luther, M.; Kenakin, T. Recombinant human CXC-chemokine receptor-4 in melanophores are linked to Gi protein: seven transmembrane coreceptors for human immunodeficiency virus entry into cells. Mol Pharmacol. 1998, 53, 177-181.

76. DeCamp, D.L.; Thompson, T.M.; de Sauvage, F.J.; Lerner, M.R. Smoothened activates Galphai-mediated signaling in frog melanophores. J Biol Chem. 2000. 275, 26322.

77. Wise, A.; Jupe, S.C.; Rees, S. The identification of ligands at orphan G-protein coupled receptors. Annu Rev Pharmacol Toxicol. 2004, 44, 43-66.

78. Milligan G. Constitutive activity and inverse agonists of G protein-coupled receptors: a current perspective. Mol Pharmacol. 2003, 64, 1271-1276.

79. Kenakin T. Inverse, protein, and ligand-selective agonism: matters of receptor conformation. FASEB J. 2001, 15, 598-611.

80. Patel, H.; Porter, R.H.; Palmer, A.M.; Croucher, M.J. Comparison of human recombinant adenosine A2B receptor function assessed by Fluo-3-AM fluorometry and microphysiometry. Br J Pharmacol. 2003. 138, 671-677.

81. Spampinato, S.; Di Toro, R.; Alessandri, M.; Murari, G. Agonist-induced internalization and desensitization of the human nociceptin receptor expressed in CHO cells. Cell Mol Life Sci. 2002. 59, 2172-2183.

82. Luttrell L.M.; Lefkowitz R.J. The role of b-arrestins in the termination and transduction of G-protein-coupled receptor signals. J Cell Sci. 2002. 115, 455-465.

83. Ghosh R.N.; Chen Y.T.; DeBiasio R.; DeBiasio R.L.; Conway B.R.; Minor L.K.; Demarest K.T. Cell-based, high-content screen for receptor internalization, recycling and intracellular trafficking. Biotechniques. 2000, 29, 170-175.

84. Oakley, R.H.; Hudson, C.C.; Cruickshank, R.D.; Meyers, D.M.; Payne, R.E. Jr.; Rhem, S.M.; Loomis, C.R. The cellular distribution of fluorescently labeled arrestins provides a robust, sensitive, and universal assay for screening G protein-coupled receptors. Assay Drug Dev Technol. 2002, 1, 21-30.

85. Milligan, G. High-content assays for ligand regulation of G-protein-coupled receptors. Drug Discov Today. 2003, 8, 579-585.

86. Bertrand, L.; Parent, S.; Caron, M.; Legault, M.; Joly, E.; Angers, S.; Bouvier, M.; Brown, M.; Houle, B.; Menard, L. The BRET2/arrestin assay in stable recombinant cells: a platform to screen for compounds that interact with G protein-coupled receptors (GPCRs). J Recept Signal Transduct Res. 2002, 22, 533-541.

87. Berglund, M.M.; Schober, D.A.; Statnick, M.A.; McDonald, P.H.; Gehlert, D.R. The use of bioluminescence resonance energy transfer 2 to study neuropeptide Y receptor agonist-induced b-arrestin 2 interaction. J Pharmacol Exp Ther. 2003, 306, 147-156.

88. Adie, E.J.; Francis, M.J.; Davies, J.; Smith, L.; Marenghi, A.; Hather, C.; Hadingham, K.; Michael, N.P.; Milligan, G.; Game, S. CypHer 5: a generic approach for measuring the activation and trafficking of G protein-coupled receptors in live cells. Assay Drug Dev Technol. 2003, 1, 251-259.

89. Lander, E.S.; Linton, L.M.; Birren, B.; Nusbaum, C.; Zody, M.C. et. al. Initial sequencing and analysis of human genome. Nature. 2001, 409, 860-921.

90. Pierce, K.L.; Premont, R.T.; Lefkowitz, R.J. Seven-transmembrane receptors. Nat Rev Mol Cell Biol. 2002, 3, 639-650.

91. Howard, A.D.; McAllister, G.; Feighner, S.D.; Liu, Q.; Nargund, R.P.; Van der Ploeg, L.H.; Patchett, A.A. Orphan G-protein-coupled receptors and natural ligand discovery. Trends Pharmacol Sci. 2001, 22, 132-140.

92. Wise, A.; Gearing, K.; Rees, S. Target validation of G-protein coupled receptors. Drug Disc Today. 2002. 7, 235-246.

93. Cacace, A.; Banks, M.; Spicer, T.; Civoli, F.; Watson, J. An ultra-HTS process for the identification of small molecule modulators of orphan G-protein coupled receptors. Drug Disc Today. 2003, 8, 785-792.

94. Howard, A.D.; McAllister, G.; Feighner, S.D.; Liu, Q.; Nargund, R.P.; Van der Ploeg, L.H.; Patchett, A.A.Orphan G-protein coupled receptors and natural ligand discovery. Trends Pharmacol Sci. 2001, 22, 132-140.

95. Civelli, O.; Nothacker, H.P; Saito, Y.; Wang, Z.; Lin, S.H.; Reinscheid, R.K. Novel neurotransmitters as natural ligands of orphan G-protein-coupled receptors. Trends Neurosci. 2001, 24, 230-237.

96. Hinuma, S.; Onda, H.; Fujino, M. The quest for novel bioactive peptides utilizing orphan seven-transmembrane-domain receptors. J Mol Med. 1999. 77, 495-504.

97. Stadel, J.M.; Wilson, S.; Bergsma, D.J. Orphan G protein-coupled receptors: a neglected opportunity for pioneer drug discovery. Trends Pharmacol Sci, 1997, 18, 430-437.

98. Wilson, S.; Bergsma, D.J.; Chambers, J.K.; Muir, A.I. Fantom, K.G.; Ellis, C.; Murdock, P.R.; Herrity, N.C.; Stadel, J.M. Orphan G-protein-coupled receptors: the next generation of drug targets? Br J Pharmacol. 1998, 125, 1387-1392.

99. Tatemoto, K.; Hosoya, M.; Habata, Y.; Fujii, R.; Kakegawa, T.; Zou, M.X.; Kawamata, Y.; Fukusumi, S.; Hinuma, S.; Kitada, C.; Kurokawa, T.; Onda, H.; Fujino, M. Isolation and characterization of a novel endogenous peptide ligand for the human APJ receptor. Biochem Biophys Res Commun. 1998, 251, 471-476.

0 0

Post a comment